Arcellx, Inc. (ACLX)

71.94 -2.14 (-2.89%) USD  |  NASDAQ  |  Dec 09, 11:32
More

Arcellx EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for ACLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Geron Corp. Upgrade
Daré Bioscience, Inc. Upgrade
Cartesian Therapeutics, Inc. Upgrade
Cabaletta Bio, Inc. Upgrade